View in EDS

Strategies to inhibit steroid cytochrome P450 enzymes to benefit human health: development of steroid ligands for P450s 17A1, 19A1, and 8B1 to treat cancer and obesity.

Saved in:
Bibliographic Details
Title: Strategies to inhibit steroid cytochrome P450 enzymes to benefit human health: development of steroid ligands for P450s 17A1, 19A1, and 8B1 to treat cancer and obesity.
Authors: Ho TM; Department of Chemistry, The University of Texas at San Antonio San Antonio TX 78249 USA francis.yoshimoto@gmail.com., Yoshimoto FK; Department of Chemistry, The University of Texas at San Antonio San Antonio TX 78249 USA francis.yoshimoto@gmail.com.
Source: RSC medicinal chemistry [RSC Med Chem] 2025 Dec 29. Date of Electronic Publication: 2025 Dec 29.
Publication Type: Journal Article; Review
Journal Info: Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 101759460 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2632-8682 (Electronic) Linking ISSN: 26328682 NLM ISO Abbreviation: RSC Med Chem
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41551023
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Strategies to inhibit steroid cytochrome P450 enzymes to benefit human health: development of steroid ligands for P450s 17A1, 19A1, and 8B1 to treat cancer and obesity.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ho+TM%22">Ho TM</searchLink>; Department of Chemistry, The University of Texas at San Antonio San Antonio TX 78249 USA francis.yoshimoto@gmail.com.<br /><searchLink fieldCode="AU" term="%22Yoshimoto+FK%22">Yoshimoto FK</searchLink>; Department of Chemistry, The University of Texas at San Antonio San Antonio TX 78249 USA francis.yoshimoto@gmail.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101759460%22">RSC medicinal chemistry</searchLink> [RSC Med Chem] 2025 Dec 29. <i>Date of Electronic Publication: </i>2025 Dec 29.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Royal+Society+of+Chemistry%22">Royal Society of Chemistry </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101759460 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2632-8682 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226328682%22">26328682 </searchLink><i>NLM ISO Abbreviation: </i>RSC Med Chem
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41551023
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1039/d5md00954e
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Strategies to inhibit steroid cytochrome P450 enzymes to benefit human health: development of steroid ligands for P450s 17A1, 19A1, and 8B1 to treat cancer and obesity.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ho TM
      – PersonEntity:
          Name:
            NameFull: Yoshimoto FK
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 29
              M: 12
              Text: 2025 Dec 29
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2632-8682
          Titles:
            – TitleFull: RSC medicinal chemistry
              Type: main
ResultId 1